RT Journal Article
SR Electronic
T1 A common model for the breathlessness experience
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.09.29.20203943
DO 10.1101/2020.09.29.20203943
A1 Finnegan, Sarah L.
A1 Pattinson, Kyle T.S.
A1 Sundh, Josefin
A1 Sköld, Magnus
A1 Janson, Christer
A1 Blomberg, Anders
A1 Sandberg, Jacob
A1 Ekström, Magnus
YR 2020
UL http://medrxiv.org/content/early/2020/09/29/2020.09.29.20203943.abstract
AB Introduction Chronic breathlessness occurs across many different diseases, independently of severity. Yet, despite being strongly linked to adverse outcomes, chronic breathlessness is generally not considered a stand-alone treatment target. Here we move focus from identifying the “best” measurement tool and use data-driven techniques to identify and confirm the stability of underlying features (factors) driving breathlessness across different cardiorespiratory diseases. Such frameworks could provide an opportunity to address the underlying mechanisms of breathlessness and over-come issues with co-morbidities, particularly when medical therapies have been optimised.Methods Longitudinal study of questionnaire data on 182 participants with main diagnoses of asthma (21.4%), COPD (24.7%), heart failure (19.2%), idiopathic pulmonary fibrosis (18.7%), other interstitial lung disease (5.5%), and “other diagnoses” (8.8%) were entered into an exploratory factor analysis (EFA). Participants were stratified based on their EFA factor scores, allowing us to examine whether the breathlessness experience differed across disease diagnosis. We then examined model stability after six months and established through an iterative process the most compact, and therefore least burdensome assessment tool.Results From the 25 input measures, 16 measures were retained for model validation. The resulting model contained four factors to which we assigned the following descriptive labels: body burden, 2) affect/mood, 3) breathing burden and 4) anger/frustration. Stratifying patients by their scores across the four factors revealed two groups corresponding to high and low burden. These were not found to be predictive of primary disease diagnosis and did remain stable after six months.Conclusions We have identified four stable and disease-independent factors that seem to underlie the experience of breathlessness. We suggest that interventions may target factors within this framework to answer the question of whether they are also driving the experience itself.Competing Interest StatementThe authors have declared no competing interest.Funding StatementDr Pattinson was supported by the JABBS Foundation, the Dunhill Medical Trust, and the NIHR Biomedical Research Centre based at Oxford University Hospitals NHS Trust and The University of Oxford.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Data for the main study which were used in this subsequent analysis was approved by the Regional Ethical Board at Lund University (DNr: 2016/16).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data used for this analysis are part of the longitudinal dataset reported as: Ekstrom, M., et al., Validation of the Swedish Multidimensional Dyspnea Profile (MDP) in outpatients with cardiorespiratory disease. BMJ Open Respiratory Research, 2019. 6(1): p. e000381